NASDAQ : INGN
Inogen, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 6.86 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 182.05M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 182.05M |
| Enterprise Value | 92.31M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 26.54M |
| Shares Outstanding | 26.54M |
| Shares Change (YoY) | +8.92% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 2.96% |
| Owned by Institutions (%) | 73.16% |
| Float | 23.13M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.51 |
| Forward PS | 0.50 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.74 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -13.14% |
| Return on Assets (ROA) | -5.84% |
| Return on Invested Capital (ROIC) | -31.97% |
| Return on Capital Employed (ROCE) | -13.01% |
| Weighted Average Cost of Capital (WACC) | 11.49% |
| Revenue Per Employee | $470,523 |
| Profits Per Employee | -$32,663 |
| Employee Count | 753 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 7.43 |
Taxes
| Measure | Value |
|---|
| Income Tax | -710,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -18.43% |
| 50-Day Moving Average | 5.84 |
| 200-Day Moving Average | 6.23 |
| Relative Strength Index (RSI) | 61.67 |
| Average Volume (20 Days) | 269,389 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.53M |
| Short Previous Month | 1.47M |
| Short % of Shares Out | 5.77% |
| Short % of Float | 6.62% |
| Short Ratio (days to cover) | 3.88 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 354.30M |
| Gross Profit | 157.69M |
| Operating Income | -27.94M |
| Pretax Income | -25.31M |
| Net Income | -24.60M |
| EBITDA | -8.09M |
| EBIT | -27.94M |
| Loss Per Share | -$0.91 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 105.54M |
| Total Debt | 15.79M |
| Net Cash | 89.75M |
| Net Cash Per Share | $3.38 |
| Equity (Book Value) | 174.86M |
| Book Value Per Share | 6.54 |
| Working Capital | 123.27M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -2.52M |
| Capital Expenditures | -7.18M |
| Depreciation & Amortization | 19.86M |
| Net Borrowing | n/a |
| Free Cash Flow | -9.69M |
| FCF Per Share | -$0.37 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.51% |
| Operating Margin | -7.89% |
| Pretax Margin | -7.14% |
| Profit Margin | -6.94% |
| EBITDA Margin | -2.28% |
| EBIT Margin | -7.89% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.92% |
| Shareholder Yield | -8.92% |
| Earnings Yield | -13.25% |
| FCF Yield | -5.32% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.00 |
| Price Target Difference | 74.93% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 4.22% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |